We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GUIDANCE ON COMBINATION PRODUCTS IS IN THE PIPELINE
GUIDANCE ON COMBINATION PRODUCTS IS IN THE PIPELINE
August 6, 2004
The FDA is in the early stages of developing a new guidance on how a genetic testing device could be co-developed with a drug or biologic to create a new combination product.